Laboratory biosecurity in the United States

In light of terrorist events in the United States and in recognition of the potential for diversion of highly pathogenic organisms for illicit purposes, the US Congress has in the past 15 years enacted a series of laws designed to enhance laboratory biosecurity. The Office of the President has also issued orders intended to implement and augment these new statutes imposing additional procedural and technical requirements on laboratories working with Select Agents and Toxins. Researchers and laboratory managers can substantially influence the implementation of new mandates with a thorough understanding of the regulatory process, reviewed in this chapter from a historical perspective with an emphasis on the practical aspects of rule-making procedures carried out by the Departments of Agriculture and Health and Human Services.

[1]  Eyes on the Prize: Lessons from the Cholera Wars for Modern Scientists, Physicians, and Public Health Officials† , 2013, The American journal of tropical medicine and hygiene.

[2]  Kathleen Carr,et al.  Implementation of biosurety systems in a Department of Defense medical research laboratory. , 2004, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[3]  Adel Mahmoud,et al.  A Workshop to Anticipate the Biosecurity Challenges of the Global Expansion of High-Containment Biological Laboratories , 2011 .

[4]  Response.  Office of the Assistant Secretary for Preparedness and Response; HHS Public Health Emergency Medical Countermeasures Enterprise implementation plan for chemical, biological, radiological and nuclear threats. Notice. , 2007 .

[5]  S. Iwanicki.  The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 , 2007 .

[6]  A. Balows.  Biotechnology research—in an age of terrorism , 2004 .

[7]  Unoda.  Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on their Destruction [BWC Convention], U.N. Doc. A/Res/2826; 1015 U.N.T.S. 163; 26 U.S.T. 583; 11 I.L.M. 309 (10 Apr. 1972) , 2001, International Terrorism: Multilateral Conventions (1937-2001).

[8]  Jonathan Y. Richmond,et al.  Biosafety in microbiological and biomedical laboratories , 1999 .

[9]  Arturo Casadevall,et al.  Microbial threat lists: obstacles in the quest for biosecurity? , 2010, Nature Reviews Microbiology.

[10]  J. Beall.  Are We Only Burning Witches? The Antiterrorism and Effective Death Penalty Act of 1996's Answer to Terrorism , 1998 .

[11]  Ola,et al.  No. 14860. Convention on the prohibition of the development, production and stockpiling of bacteriological (biological) and toxin weapons and on their destruction. Opened for signature at London, Moscow and Washington on 10 April 1972 , 2000 .

[12]  Christopher Anglim,et al.  USA Patriot Act : a legislative history of the Uniting and Strengthening of America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act, Public Law no. 107-56 (2001) , 2002 .

[13]  S. Matthews.  Select-agent status could slow development of anti-SARS therapies , 2012, Nature Medicine.

[14]  Dana A. Shea,et al.  Oversight of Dual-Use Biological Research: The National Science Advisory Board for Biosecurity , 2006 .

[15]  États-Unis.  Uniting and strengthening America by providing appropriate tools required to intercept and obstruct terrorism (USA patriot act) Act of 2001 , 2001 .

[16]  W. Emmett Barkley,et al.  Biosafety in microbiological and biomedical laboratories , 1984 .

[17]  George W. Bush,et al.  Executive Order 13486: Strengthening Laboratory Biosecurity in the United States , 2009 .

[18]  M. Ferson,et al.  Staff immunisation: Policy and practice in child care , 2011, Journal of paediatrics and child health.

[19]  M. Singer,et al.  Summary statement of the Asilomar conference on recombinant DNA molecules. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[20]  The scientific background of the International Sanitary Conferences 1851–1938 , 1974, WHO chronicle.

[21]  Elizabeth A. Casman,et al.  Effects of the USA PATRIOT Act and the 2002 Bioterrorism Preparedness Act on select agent research in the United States , 2010, Proceedings of the National Academy of Sciences.